Literature DB >> 10971142

Differential regulation of prolactin release and lactotrope proliferation during pregnancy, lactation and the estrous cycle.

P Yin1, J Arita.   

Abstract

The proestrous surge of prolactin (PRL) secretion and subsequent proliferation of lactotropes at estrus have been suggested to be induced by a common hypothalamic hormone. We investigated changes in lactotrope proliferation at other reproductive stages of female rats when PRL secretion was stimulated. To assess proliferative activity of lactotropes, incorporation of 5-bromo-2'-deoxyuridine (BrdU) into DNA was measured by double immunostaining for PRL and BrdU. BrdU-labeling indices, determined by BrdU injections at 10.00 h, revealed low levels of proliferative activity of lactotropes at the reproductive stages including diestrus, days 6 and 13 of pregnancy, and day 6 of lactation while high levels were detected on estrus and the day of parturition. When BrdU-labeling indices were determined at 3-hour intervals through day 6 of pregnancy to find an increase in lactotrope proliferation which might occur at times other than 10.00 h, proliferative activity of lactotropes remained at low levels with a slight increase in the afternoon. Such a diurnal change as observed in early pregnancy was not detected on day 13 of pregnancy. In contrast, short-interval determinations of BrdU-labeling indices during a period from day 20 of pregnancy to day 2 of lactation revealed a marked increase in proliferative activity on the day of parturition with a peak at 18.00 h, which was comparable to that observed at estrus. To investigate involvement of ovarian steroids in suppression of lactotrope proliferation as observed during early pregnancy and lactation, ovariectomized and pup-removed lactating rats were given one of treatment combinations of estradiol and suckling. In pup-removed lactating rats, estradiol treatment alone induced neither a PRL surge nor an increase in BrdU-labeling indices. Suckling stimuli, which were effective in increasing serum PRL concentrations irrespective of estradiol treatment, elicited a marked increase in BrdU-labeling indices in the presence of estradiol but not in its absence. These results suggest that proliferative activity of rat lactotropes does not necessarily correlate with PRL secretion during pregnancy and lactation. In contrast to PRL release, lactotrope proliferation requires both a hypophysiotropic stimulatory input from the hypothalamus and a sensitizing action of estradiol, an observation which may account for the fact that proliferation does not occur during pregnancy and lactation in spite of elevated PRL release. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971142     DOI: 10.1159/000054574

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  12 in total

1.  Research resource: A genome-wide study identifies potential new target genes for POU1F1.

Authors:  Jean-Paul Herman; Nicolas Jullien; Séverine Guillen; Alain Enjalbert; Isabelle Pellegrini; Jean-Louis Franc
Journal:  Mol Endocrinol       Date:  2012-05-25

2.  Gonadal steroids modulate Fas-induced apoptosis of lactotropes and somatotropes.

Authors:  Gabriela Jaita; Sandra Zárate; Luciana Ferrari; Daniela Radl; Jimena Ferraris; Guadalupe Eijo; Verónica Zaldivar; Daniel Pisera; Adriana Seilicovich
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

3.  Colloid in the anterior pituitary of helmet guinea fowl (Numida meleagris galeata): morphometric analysis and pattern of occurrence in relation to apoptosis.

Authors:  Claudius Luziga; Maulilio John Kipanyula; Gabriel Mbassa; Mamba Koichi
Journal:  Vet Res Commun       Date:  2009-03-17       Impact factor: 2.459

4.  Functional role of estrogen in pituitary tumor pathogenesis.

Authors:  Anthony P Heaney; Manory Fernando; Shlomo Melmed
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Expression of estrogen receptor α and growth factors in human prolactinoma and its correlation with clinical features and gender.

Authors:  H Lv; C Li; S Gui; Y Zhang
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

6.  Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line.

Authors:  Hongtao Lv; Chuzhong Li; Songbai Gui; Meizhen Sun; Dan Li; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2010-08-11       Impact factor: 4.130

7.  Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.

Authors:  Shenglin Chen; Madhavi Latha Yadav Bangaru; Leighton Sneade; Joseph A Dunckley; Nira Ben-Jonathan; Sanjay Kansra
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-26       Impact factor: 4.310

8.  Estradiol partially recapitulates murine pituitary cell cycle response to pregnancy.

Authors:  Yoel Toledano; Svetlana Zonis; Song-Guang Ren; Kolja Wawrowsky; Vera Chesnokova; Shlomo Melmed
Journal:  Endocrinology       Date:  2012-07-31       Impact factor: 4.736

9.  The involvement of angiotensin type 1 and type 2 receptors in estrogen-induced cell proliferation and vascular endothelial growth factor expression in the rat anterior pituitary.

Authors:  Hanna Lawnicka; Dorota Ptasinska-Wnuk; Slawomir Mucha; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  ScientificWorldJournal       Date:  2012-04-26

10.  Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists.

Authors:  Muriel Babey; Rahel Sahli; Istvan Vajtai; Robert H Andres; Rolf W Seiler
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.